Sort
23,748 grants matching “melanoma”
Developing new immunotherapies based of CD4 T cells
$768,394Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Accuracy in the Diagnosis of Melanoma & the Impact of Double Reading
$767,869Joann G Elmore · University Of Washington · R01 · FY2015 · CA
ADMINISTRATION (Admin Core)
$767,316Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
Functional assessment of genes and common genetic risk variants in ovarian cancer
$767,203Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · U19 · FY2012 · CA
CCR Confocal Microscopy Core
$767,104Susan Garfield · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases
$767,049James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2013 · DK
Developing new immunotherapies based of CD4+ T cells
$766,780Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
$766,294Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$766,137Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Molecular Analysis of Breast Cancer Metastasis to the Brain
$765,528Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
$765,000Zachary Scott Morris · University Of Wisconsin-Madison · U01 · FY2020 · CA
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
$765,000Zachary Scott Morris · University Of Wisconsin-Madison · U01 · FY2018 · CA
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
$765,000Zachary Scott Morris · University Of Wisconsin-Madison · U01 · FY2022 · CA
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
$765,000Zachary Scott Morris · University Of Wisconsin-Madison · U01 · FY2019 · CA
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
$765,000Zachary Scott Morris · University Of Wisconsin-Madison · U01 · FY2021 · CA
ADMINISTRATION (Admin Core)
$764,965Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA
Functional genomic analysis of neural crest development
$764,833William J Pavan · National Human Genome Research Institute · ZIA · FY2013 · HG
Analysis of Dominant Megacolon: Another Hirschsprung Disease Model
$764,833William J Pavan · National Human Genome Research Institute · ZIA · FY2013 · HG
Regulation of interferon signaling in melanoma by the cohesin complex protein STAG2 via 3D genome organization
$764,025Bin Zheng · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Missouri Valley Cancer Consortium CCOP
$763,999Missouri Valley Cancer Consortium, Inc. · U10 · FY2003 · CA
Structural Biology of GTPase Activating Proteins
$763,712Robert Byrd · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Novel SCD1 inhibitors for treatment of cancer
$763,181John A Copland · Modulation Therapeutics, Inc. · R42 · FY2018 · CA
Immunobiology of Pediatric Tumors
$763,115Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
UNRAVELING IMMUNOSUPPRESSIVE TRAFFICKING IN MELANOMA
$762,423University Of Utah · · FY2022 · Defense Health Agency
Molecular Diagnostics And Support
$762,172Dave S B Hoon · Saint John'S Cancer Institute · P01 · FY2012 · CA